---
category: news
title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"
excerpt: "“As each patient’s cancer is unique, we have developed a therapy that turns their ... from its world-leading expertise in artificial intelligence and its unique algorithm that is used to ..."
publishedDateTime: 2020-01-07T00:12:00Z
sourceUrl: https://www.businesswire.com/news/home/20200106006021/en/Transgene-NEC-Start-Clinical-Trials-TG4050-AI-Powered
type: article
quality: 14
heat: 14
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI
  - AI in Healthcare

images:
  - url: https://mms.businesswire.com/media/20200106006021/en/765262/23/NEC.jpg
    width: 1200
    height: 627
    title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"

secured: "kXvoePygQ9ZrgpAZzW5UxtCj7NukQBjlZj8iRrkZ+D6fZVmaVPRm1TqAQRY3UFPJ/qdtJFAeopLnthFyw1kxhgLe/5v9ENR+Y+FJUsP/BnnX2LqXxRHR2cJrBd55qtK95I0/rq2FoKMcZurykx48jOoaxNX2uC9jNAxzDdnUK4JC7lXqhfE+yiQizS9wc2EccEfy6sknxD7XZakQT6F9OyOhOiFGhsYttQXoTVp9CVUBx3U/IJrSPoOMB/Kit+AcAfKkoHJ6AAAiy/rJZBG1lLcr3HI15CRgw9HiRo3hRTD57Pg7hf4YQKfyAcSqZ/V3;Rf2u/weI3i7XWphCae+zHg=="
---

